A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study
Clinical trial NCT03691662 · COMPLETED
Trial details
- NCT number
- NCT03691662
- Sponsor
- Santen Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-27
- Primary completion
- 2019-10-23
- Enrollment
- 417
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.